Michael Alifrangis

Michael Alifrangis

Associate Professor

Member of:

  • DRUGS team

ORCID: 0000-0002-3835-3333

Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2024
  2. Published

    Seasonal malaria chemoprevention therapy in children up to 9 years of age: Protocol for a cluster-randomized trial study

    Toure, M., Shaffer, J. G., Sanogo, D., Keita, S., Keita, M., Kane, F., Traore, B., Dabitao, D., Kone, A., Doumbia, C. O., Keating, J., Yukich, J., Hansson, Helle Smedegaard, Barry, A. E., Diakité, M., Alifrangis, Michael & Doumbia, S., 22 Jan 2024, In: JMIR Research Protocols. 13, p. e51660

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo

    Mesia Kahunu, G., Wellmann Thomsen, S., Wellmann Thomsen, L., Muhindo Mavoko, H., Mitashi Mulopo, P., Hocke, Emma Filtenborg, Mandoko Nkoli, P., Baraka, V., Minja, D. T. R., Mousa, A., Roper, C., Mbongi Moke, D., Mumba Ngoyi, D., Mukomena Sompwe, E., Muyembe Tanfum, J. J., Hansson, Helle Smedegaard & Alifrangis, Michael, 2024, In: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 139, p. 41-49 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 11975